- Original research
- Open access
- Published:
Transthoracic ultrasonographic features of diffuse parenchymal lung diseases
Egyptian Journal of Bronchology volume 11, pages 179–187 (2017)
Abstract
Objectives
The value of transthoracic ultrasonography (TTUS) in diffuse parenchymal lung disease (DPLD) has not been established yet. This prospective study was conducted to assess pleural and parenchymal alterations in patients with DPLD by TTUS and to compare the results with chest high-resolution computed tomography (HRCT). The results of TTUS were compared with some arterial blood gas (ABG) parameters and 6-min walk test (6MWT).
Patients and methods
This study was conducted on 50 patients. All patients underwent HRCT, resting ABGs, and 6MWT, in addition to TTUS to evaluate (a) the presence and number of B-line and distance between them, (b) pleural effusion, (c) pleural thickening, (d) an irregular, fragmented pleural line, and (e) subpleural alterations.
Results
The studied group showed female predominance, wide range of age, and most of them were nonsmokers. All patients had diffuse bilateral B-lines. B-line numbers were inversely correlated with severity of pulmonary fibrosis detected by HRCT modified Warrick score; however, distance between B-lines was directly correlated with severity of pulmonary fibrosis. Some ABGs (resting PaO2, resting SpO2%, AaDO2) and 6MWT parameters were correlated with B-line number and distance between them. As detected by TTUS, the majority of patients (82%) had irregular thickened pleural line, whereas 44% of them had absent lung sliding.
Conclusion
TTUS can play a complementary role in the diagnosis and monitoring of DPLD patients. Multiple B-lines distributed over the entire lung surface in combination with a thickened, irregular, and fragmented pleural line are strongly suggestive of the presence of DPLD. TTUS gives an idea about diffuse or limited, early, or advanced DPLD.
References
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.
Anderson KL, Fields JM, Panebianco NL, Jenq KY, Marin J, Dean AJ. Inter-rater reliability of quantifying pleural B-lines using multiple counting methods. J Ultrasound Med 2013; 32:115–120.
Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, et al. International evidence-based recommendations for point of care lung ultrasound. Intensive Care Med 2012; 38:577–591.
Saha K. Review article. Interstitial lung disease: diagnostic approach. J Assoc Chest Physicians 2014; 2:3–15.
Dexheimer Neto FL, Dalcin PR, Teixeira C, Beltrami FG. Lung ultrasound in critically ill patients: a newdiagnostictool. J Bras Pneumol 2012; 38:246–256.
Copetti R, Soldati G, Copetti P. Chest sonography: a useful tool to differentiate acute cardiogenic pulmonary edema from acute respiratory distress syndrome. Cardiovasc Ultrasound 2008; 6:16.
American Thoracic Society (ATS). American Thoracic Society (ATS) Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
Nici L, ZuWallack R. An official American Thoracic Society Workshop Report: the integrated care of the COPD patient. Proc Am Thorac Soc 2012; 9:9–18.
American Association for Respiratory Care. Clinical practice guideline: exercise test for evaluation of hypoxemia and/or desaturation. Respir Care 2001; 46:514–522.
Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991; 18:1520–1528.
Bolliger CT, Herth FJF, Mayo PH, Miyazawa T, Beamis JF. Clinical chest ultrasound: from the ICU to the bronchoscopy suite. Prog Respir Res 2009; 37:22–33.
Behr J. Approach to the diagnosis of interstitial lung disease. Clin Chest Med 2012; 33:1–10.
Leslie KO. My approach to interstitial lung disease using clinical, radiological and histopathological patterns. J Clin Pathol 2009; 62:387–401.
Launay D, Remy-Jardin M, Michon-Pasturel U, Mastora I, Hachulla E, Lambert M, et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006; 33: 1789–1801. [PubMed].
Kanne JP. Interstitial lung disease (ILD): imaging finding, and the role of imaging in evaluating the patient with known or suspected ILD. Semin Roentgenol 2010; 45:3.
Meyer KC. Diagnosis and management of interstitial lung disease. Transl Respir Med 2014; 2:4.
Hasan A, Makhlouf H. B-lines: transthoracic chest ultrasound signs useful in assessment of interstitial lung diseases. Ann Thorac Med 2014; 9:99–103.
Cogliati C, Antivalle M, Torzillo D, Birocchi S, Norsa A, Bianco R, et al. Standard and pocket-size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patients. Rheumatology 2014; 53:1497–1503.
Mohammadi A, Oshnoei S, Ghasemi-rad M. Comparison of a new modified lung ultrasonography technique with high-resolution CT in the diagnosis of the alveolo-interstitial syndrome of systemic scleroderma. Med Ultrason 2014; 16:27–31.
Gargani L, Doveri M, D’Errico L, Frassi F, Bazzichi ML, Delle Sedie A, et al. Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology 2009; 48:1382–1387.
Bouhemad B, Zhang M, Lu Q, Rouby JJ. Clinical review: bedside lung ultrasound in critical care practice. Crit Care 2007; 11:205–222.
Lichtenstein D, Mézière G, Biderman P, Gepner A, Barré O. The comet-tail artifact. An ultrasound sign of alveolar-interstitial syndrome. Am J Respir Crit Care Med 1997; 156:1640–1646.
Reissig A, Kroegel C. Transthoracic sonography of diffuse parenchymal lung disease: the role of comet tail artifacts. J Ultrasound Med 2003; 22:173–180.
Sperandeo M, Varriale A, Sperandeo G, Filabozzi P, Piattelli ML, Carnevale V, et al. Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med Biol 2009; 35:723–729.
Soldati G, Copetti R, Sher S. Sonographic interstitial syndrome: the sound of lung water. J Ultrasound Med 2009; 28:163–174.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Farag, T.S., Adawy, Z.R., Sakr, L.K. et al. Transthoracic ultrasonographic features of diffuse parenchymal lung diseases. Egypt J Bronchol 11, 179–187 (2017). https://doi.org/10.4103/ejb.ejb_3_17
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejb.ejb_3_17